Description: Global pharmaceutical company Sanofi is committed to significantly improve the health and lives of people with rare blood disorders around the world.
cancer (3276) oncology (581) cancer treatment (254) hematology (83) fight cancer (10) global cancer community (1) aging in cancer (1) cancer and aging (1) hemophilia pipeline (1) hemophilia research & development (1)
Our Company Our Company Our Strategy Governance Governance Board of Directors Executive Committee Specialist Committees Social Impact Social Impact Access to Healthcare Innovation for Vulnerable Communities Environmental Sustainability and Resilience Diversity, Equity, and Inclusion In and Beyond the Workplace Responsible Business Values Our Legacy Our Science Our Science Our Pipeline R&D Focus Areas R&D Focus Areas Immunology R&D Neurology R&D Oncology R&D Rare Blood Disorders R&D Rare Diseases R&D Vaccine
The world’s population is aging more quickly than ever before. By 2050, the number of people over 60 is expected to double. 1 People with cancer are also growing older. Approximately 37% of new cancer cases around the world are diagnosed in people older than 70, 2 and this number is predicted to more than double by 2040. 3 This staggering trend will place a significant burden on individuals, families, communities and healthcare systems worldwide. 4
Older people with cancer and their families often face inconsistent treatment and prevention guidance, 4,5,6 additional health problems that require customized care, 4,7 and lack of access to relevant information, resources and post-treatment support. 7,8,9